Methotrexate vs other DMARDsSerious adverse events (leflunomide) assessed by number of events · psoriatic arthritis1 finding from 1 reviewMethotrexate for psoriatic arthritis 2019 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 61 participantsVery low